| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 0N3FY8225K |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Glaucoma; Glaucoma, Neovascular; Ischemia; Retinal Vein Occlusion | Phase 2/Phase 3 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1146887-67-3 |
| ChEMBL | CHEMBL2108296 |
| FDA SRS | 0N3FY8225K |
CONTENTS